Found: 74
Select item for more details and to access through your institution.
Machine learning identifies factors most associated with seeking medical care for migraine: Results of the OVERCOME (US) study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 8, p. 1027, doi. 10.1111/head.14729
- By:
- Publication type:
- Article
Hyphal Als proteins act as CR3 ligands to promote immune responses against Candida albicans.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48093-8
- By:
- Publication type:
- Article
Comparing the Efficacy and Safety of Galcanezumab Versus Rimegepant for Prevention of Episodic Migraine: Results from a Randomized, Controlled Clinical Trial.
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 1, p. 85, doi. 10.1007/s40120-023-00562-w
- By:
- Publication type:
- Article
Investigation of the Effect of Lasmiditan on the Pharmacokinetics of P‐Glycoprotein and Breast Cancer Resistance Protein Substrates.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 1, p. 94, doi. 10.1002/jcph.2328
- By:
- Publication type:
- Article
NLRP3 selectively drives IL-1β secretion by Pseudomonas aeruginosa infected neutrophils and regulates corneal disease severity.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41391-7
- By:
- Publication type:
- Article
CCR2-positive monocytes contribute to the pathogenesis of early diabetic retinopathy in mice.
- Published in:
- Diabetologia, 2023, v. 66, n. 3, p. 590, doi. 10.1007/s00125-022-05860-w
- By:
- Publication type:
- Article
Pyroptosis in neutrophils: Multimodal integration of inflammasome and regulated cell death signaling pathways.
- Published in:
- Immunological Reviews, 2023, v. 314, n. 1, p. 229, doi. 10.1111/imr.13186
- By:
- Publication type:
- Article
A phase IV clinical trial of gastrointestinal motility in adult patients with migraine before and after initiation of a calcitonin gene‐related peptide ligand (galcanezumab) or receptor (erenumab) antagonist.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 9, p. 1164, doi. 10.1111/head.14390
- By:
- Publication type:
- Article
Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 2, p. 122, doi. 10.1111/head.14259
- By:
- Publication type:
- Article
Control of β-glucan exposure by the endo-1,3-glucanase Eng1 in Candida albicans modulates virulence.
- Published in:
- PLoS Pathogens, 2022, v. 18, n. 1, p. 1, doi. 10.1371/journal.ppat.1010192
- By:
- Publication type:
- Article
A close association of freedom from pain, migraine-related functional disability, and other outcomes: results of a post hoc analysis of randomized lasmiditan studies SAMURAI and SPARTAN.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01303-w
- By:
- Publication type:
- Article
Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc Analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Early onset of effect following galcanezumab treatment in patients with previous preventive medication failures.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01230-w
- By:
- Publication type:
- Article
Onset, Maintenance, and Cessation of Effect of Galcanezumab for Prevention of Migraine: A Narrative Review of Three Randomized Placebo-Controlled Trials.
- Published in:
- Advances in Therapy, 2021, v. 38, n. 3, p. 1614, doi. 10.1007/s12325-021-01632-x
- By:
- Publication type:
- Article
Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine.
- Published in:
- Cephalalgia, 2021, v. 41, n. 3, p. 340, doi. 10.1177/0333102420966658
- By:
- Publication type:
- Article
Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01215-9
- By:
- Publication type:
- Article
Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double‐Blind, Placebo‐Controlled REGAIN, and Pooled EVOLVE‐1 and EVOLVE‐2 Studies
- Published in:
- Headache: The Journal of Head & Face Pain, 2020, v. 60, n. 10, p. 2202, doi. 10.1111/head.13970
- By:
- Publication type:
- Article
Effects of lasmiditan on simulated driving performance: Results of two randomized, blinded, crossover studies with placebo and active controls.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2020, v. 35, n. 5, p. 1, doi. 10.1002/hup.2732
- By:
- Publication type:
- Article
Assessment of immunogenicity from galcanezumab phase 3 trials in patients with episodic or chronic migraine.
- Published in:
- 2020
- By:
- Publication type:
- journal article
N-GSDMD trafficking to neutrophil organelles facilitates IL-1β release independently of plasma membrane pores and pyroptosis.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-16043-9
- By:
- Publication type:
- Article
Efficacy and Safety of Galcanezumab for the Preventive Treatment of Migraine: A Narrative Review.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Delineating the role of MITF isoforms in pigmentation and tissue homeostasis.
- Published in:
- Pigment Cell & Melanoma Research, 2020, v. 33, n. 2, p. 279, doi. 10.1111/pcmr.12828
- By:
- Publication type:
- Article
What Are the Functions of Chitin Deacetylases in Aspergillus fumigatus ?
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2020, v. 10, p. 1, doi. 10.3389/fcimb.2020.00028
- By:
- Publication type:
- Article
The genome of opportunistic fungal pathogen Fusarium oxysporum carries a unique set of lineage-specific chromosomes.
- Published in:
- Communications Biology, 2020, v. 3, n. 1, p. 1, doi. 10.1038/s42003-020-0770-2
- By:
- Publication type:
- Article
Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study).
- Published in:
- 2019
- By:
- Publication type:
- journal article
NLRP3, NLRP12, and IFI16 Inflammasomes Induction and Caspase-1 Activation Triggered by Virulent HSV-1 Strains Are Associated With Severe Corneal Inflammatory Herpetic Disease.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01631
- By:
- Publication type:
- Article
Efficacy of galcanezumab in patients with chronic migraine and a history of preventive treatment failure.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Aspergillus fumigatus corneal infection is regulated by chitin synthases and by neutrophil–derived acidic mammalian chitinase.
- Published in:
- European Journal of Immunology, 2019, v. 49, n. 6, p. 918, doi. 10.1002/eji.201847851
- By:
- Publication type:
- Article
Breaching bacterial biofilm with neutrophil α‐mannosidase.
- Published in:
- Journal of Leukocyte Biology, 2019, v. 105, n. 6, p. 1085, doi. 10.1002/JLB.4CE0419-139R
- By:
- Publication type:
- Article
Response to Misused and Misleading: 100% Response Rate to Galcanezumab in Patients With Episodic Migraine.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Analysis of Initial Nonresponders to Galcanezumab in Patients With Episodic or Chronic Migraine: Results From the EVOLVE‐1, EVOLVE‐2, and REGAIN Randomized, Double‐Blind, Placebo‐Controlled Studies.
- Published in:
- Headache: The Journal of Head & Face Pain, 2019, v. 59, n. 2, p. 192, doi. 10.1111/head.13443
- By:
- Publication type:
- Article
Sustained release of decorin to the surface of the eye enables scarless corneal regeneration.
- Published in:
- NPJ Regenerative Medicine, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41536-018-0061-4
- By:
- Publication type:
- Article
Basic Considerations for the Use of Monoclonal Antibodies in Migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2018, v. 58, n. 10, p. 1689, doi. 10.1111/head.13439
- By:
- Publication type:
- Article
100% Response Rate to Galcanezumab in Patients With Episodic Migraine: A Post Hoc Analysis of the Results From Phase 3, Randomized, Double‐Blind, Placebo‐Controlled EVOLVE‐1 and EVOLVE‐2 Studies.
- Published in:
- Headache: The Journal of Head & Face Pain, 2018, v. 58, n. 9, p. 1347, doi. 10.1111/head.13427
- By:
- Publication type:
- Article
Protein Deiminase 4 and CR3 Regulate Aspergillus fumigatus and β-Glucan-Induced Neutrophil Extracellular Trap Formation, but Hyphal Killing Is Dependent Only on CR3.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.01182
- By:
- Publication type:
- Article
Polymeric Nanofiber/Antifungal Formulations Using a Novel Co-extrusion Approach.
- Published in:
- AAPS PharmSciTech, 2017, v. 18, n. 6, p. 1917, doi. 10.1208/s12249-016-0664-2
- By:
- Publication type:
- Article
Neutrophil P2X<sub>7</sub> receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP.
- Published in:
- Nature Communications, 2016, v. 7, n. 2, p. 10555, doi. 10.1038/ncomms10555
- By:
- Publication type:
- Article
CONFERENCE CLUB.
- Published in:
- 2015
- By:
- Publication type:
- Proceeding
BRAIN PAIN AND MIGRAINE VARIANTS... [including commentary by Christina Szperka].
- Published in:
- Contemporary Pediatrics, 2015, v. 32, n. 11, p. 24
- By:
- Publication type:
- Article
Tyrosine phosphatase SHP-2 mediates C-type lectin receptor-induced activation of the kinase Syk and anti-fungal T<sub>H</sub>17 responses.
- Published in:
- Nature Immunology, 2015, v. 16, n. 6, p. 642, doi. 10.1038/ni.3155
- By:
- Publication type:
- Article
Erratum: Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORγt and dectin-2.
- Published in:
- Nature Immunology, 2015, v. 16, n. 2, p. 214, doi. 10.1038/ni0215-214a
- By:
- Publication type:
- Article
Interleukin 17 expression in peripheral blood neutrophils from fungal keratitis patients and healthy cohorts in southern India.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Mgat2 ablation in the myeloid lineage leads to defective glycoantigen T cell responses.
- Published in:
- Glycobiology, 2014, v. 24, n. 3, p. 262, doi. 10.1093/glycob/cwt107
- By:
- Publication type:
- Article
Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORγt and dectin-2.
- Published in:
- Nature Immunology, 2014, v. 15, n. 2, p. 143, doi. 10.1038/ni.2797
- By:
- Publication type:
- Article
Diversity of Virulence Phenotypes among Type III Secretion Negative <i>Pseudomonas aeruginosa</i> Clinical Isolates.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0086829
- By:
- Publication type:
- Article
MyD88-Dependent Pathways in Leukocytes Affect the Retina in Diabetes.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0068871
- By:
- Publication type:
- Article
Targeting Iron Acquisition Blocks Infection with the Fungal Pathogens <i>Aspergillus fumigatus</i> and <i>Fusarium oxysporum</i>.
- Published in:
- PLoS Pathogens, 2013, v. 9, n. 7, p. 1, doi. 10.1371/journal.ppat.1003436
- By:
- Publication type:
- Article
Host Response and Bacterial Virulence Factor Expression in <i>Pseudomonas aeruginosa</i> and <i>Streptococcus pneumoniae</i> Corneal Ulcers.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0064867
- By:
- Publication type:
- Article
Corneal Inflammation Is Inhibited by the LFA-1 Antagonist, Lifitegrast (SAR 1118).
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2013, v. 29, n. 4, p. 395, doi. 10.1089/jop.2012.0102
- By:
- Publication type:
- Article